Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2017, Article ID 6095205, 9 pages
https://doi.org/10.1155/2017/6095205
Research Article

The Prognostic Role of NEDD9 and P38 Protein Expression Levels in Urinary Bladder Transitional Cell Carcinoma

1Department of Pathology, Faculty of Medicine, Zagazig University, Sharkia, Egypt
2Department of Medical Oncology, Faculty of Medicine, Zagazig University, Sharkia, Egypt
3Department of Urology, Faculty of Medicine, Zagazig University, Sharkia, Egypt
4Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Zagazig University, Sharkia, Egypt

Correspondence should be addressed to Rasha Haggag; moc.oohay@hmmr_rd

Received 17 July 2016; Revised 15 October 2016; Accepted 18 October 2016; Published 17 January 2017

Academic Editor: Akira Hara

Copyright © 2017 Ola A. Harb et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Mokhtar, I. Gouda, and I. Adel, “Cancer Pathology Registry 2003-2004 and time trend analysis,” Journal of the Egyptian National Cancer Institute, vol. 19, no. 2, pp. 158–162, 2007. View at Google Scholar
  3. G. Dalbagni and H. W. Herr, “Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer,” Urologic Clinics of North America, vol. 27, no. 1, pp. 137–146, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Kapur, Y. Lotan, E. King et al., “Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers,” American Journal of Clinical Pathology, vol. 135, no. 6, pp. 822–830, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Wang, L. Bi, H. Wang et al., “NEDD9 rs760678 polymorphism and the risk of Alzheimer's disease: a meta-analysis,” Neuroscience Letters, vol. 527, no. 2, pp. 121–125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Cuadrado and A. R. Nebreda, “Mechanisms and functions of p38 MAPK signalling,” Biochemical Journal, vol. 429, no. 3, pp. 403–417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Sobin and C. Wittekind, TNM Classification of Malignant Tumours, Wiley-Liss, New York, NY, USA, 2002. View at Publisher · View at Google Scholar
  8. J. N. Eble, G. Sauter, J. I. Epstein, and I. A. Sesterhenn, World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, ARC Press, Lyon, France, 2004.
  9. S. M. Hsu, L. Raine, and H. Fanger, “Use of Avidin-Biotin-Peroxidase Complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures,” Journal of Histochemistry and Cytochemistry, vol. 29, no. 4, pp. 577–580, 1981. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Natarajan, J. E. Stewart Jr., E. A. Golemis et al., “HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells,” Oncogene, vol. 25, no. 12, pp. 1721–1732, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Li, J. H. Bavarva, Z. Wang et al., “HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression,” Oncogene, vol. 30, no. 23, pp. 2633–2643, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. A. Molinolo, S. M. Hewitt, P. Amornphimoltham et al., “Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative,” Clinical Cancer Research, vol. 13, no. 17, pp. 4964–4973, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. Q. Zhang, H.-J. Wang, D.-H. Zhang, G.-Q. Ru, X.-J. He, and Y.-Y. Ma, “High expression of HEF1 is associated with poor prognosis in urinary bladder carcinoma,” OncoTargets and Therapy, vol. 7, pp. 1319–1326, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Shi, L. Wang, T. Wang, J. Xu, F. Wang, and M. Xu, “NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma,” Medical Oncology, vol. 31, no. 3, article 852, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Kondo, S. Iwata, T. Yamada et al., “Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer,” Clinical Cancer Research, vol. 18, no. 22, pp. 6326–6338, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. C. Speranza, V. Frattini, F. Pisati et al., “NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma,” Oncotarget, vol. 3, no. 7, pp. 723–734, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Kim, J. D. Gans, C. Nogueira et al., “Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene,” Cell, vol. 125, no. 7, pp. 1269–1281, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Bradbury, M. Mahmassani, J. Zhong et al., “PP2A phosphatase suppresses function of the mesenchymal invasion regulator NEDD9,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1823, no. 2, pp. 290–297, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Liu, D. Wang, K.-L. Zhao et al., “NEDD9 overexpression correlates with poor prognosis in gastric cancer,” Tumor Biology, vol. 35, no. 7, pp. 6351–6356, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Kumar, J. Sinclair, L. Khandrika, S. Koul, S. Wilson, and H. K. Koul, “Differential effects of MAPKs signaling on the growth of invasive bladder cancer cells,” International Journal of Oncology, vol. 34, no. 6, pp. 1557–1564, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Thomas, M. Stedman, and L. Davies, “Grade as a prognostic factor in oral squamous cell carcinoma: a population-based analysis of the data,” The Laryngoscope, vol. 124, no. 3, pp. 688–694, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. H. K. Koul, M. Pal, and S. Koul, “Role of p38 MAP kinase signal transduction in solid tumors,” Genes and Cancer, vol. 4, no. 9-10, pp. 342–359, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. F. Law, G. M. O'Neill, S. J. Fashena, M. B. Einarson, and E. A. Golemis, “The docking protein HEF1 is an apoptotic mediator at focal adhesion sites,” Molecular and Cellular Biology, vol. 20, no. 14, pp. 5184–5195, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Matsumoto, K. Yokote, K. Tamura et al., “Platelet-derived growth factor activates p38 mitogen-activated protein kinase through a Ras-dependent pathway that is important for actin reorganization and cell migration,” Journal of Biological Chemistry, vol. 274, no. 20, pp. 13954–13960, 1999. View at Publisher · View at Google Scholar · View at Scopus